次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

医療用3Dプリント製品および技術の世界市場2015-2025年:市場予測、研究開発と業界動向

3D Printing for Healthcare: R&D, Industry and Market 2015-2025

出版元:Visiongain(英国)出版元情報LinkIcon
発行年:2015年1月
定価 Single User License(1名様ライセンス) 1,799 GBP(英国ポンド) / Department License(5名様ライセンス) 2,999GBP/ Site License 4,999GBP / Global Site License 6,999GBP
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email (※デジタル著作権管理/DRM設定有り)
当調査レポートは英文215ページになります。
商品コード:VGN328

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
医療用3Dプリント製品・技術の世界市場は2019年に28億7900万ドルに達し、2025年に向けて急速な成長が予測されます。当レポートでは、同市場の2015-2025年市場予測、詳細な製品セグメント別予測分析、主要国別分析、研究開発動向、専門家オピニオンインタビュー、リーディング企業情報などを織り交ぜ、概略以下の構成でお届けいたします。

【レポート構成概要】VGN328_3D Printing for Healthcare R&D, Industry and Market 2015-2025 Cover.jpg
・医療用3Dプリント製品、技術の世界市場予測2015-2025年
・全215ページ、57個のデータ表、53個のチャート類で定量分析
・市場成長率、市場シェア情報

・セグメント別市場予測2015-2025
(製品)
- 歯科製品
- 医療用インプラント製品
- バイオプリント組織
- その他製品
(技術)
- 技術市場

・主要11ヶ国、国別市場予測2015-2025
- 米国
- 日本
- ドイツ、フランス、英国、イタリア、スペイン(EU5国別)
- ブラジル、ロシア、インド、中国(BRIC国別)

・研究開発パイプライン詳細分析
・市場動向(開発、製造、販売)
- テクノロジー:選択的レーザ焼結(SLS)、直接金属レーザ焼結(DMLS)、電子ビーム溶解(EBM)、ステレオリソグラフィ(SLA)、バイオプリント
- 整形外科と頭蓋・顎顔面インプラント、医療モデリング、試作品(prototype)、医薬品
- 規制要件の簡略化、技術革新と課題
- 椎間板、バイオニック器官、生物工学、皮膚移植、移植可能な軟骨、人工血管、肝臓組織、心臓弁および再建手術
- その他研究開発の進歩。生体適合性の改善、機能強化への取り組み

・主要企業情報
- Stratasys
- 3D Systems
- Tissue Regeneration Systems
- Oxford Performance Materials
- Within Technologies
- Tronrud Engineering
- Alphaform
- Arcam.

・専門家オピニオンインタビュー
- Michael Renard, Executive Vice President, Commercial Operations, Organovo
- Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
- Matthew Sherry, Managing Director, Replica 3dm
- Professor Lee Cronin, Regius Chair of Chemistry, University of Glasgow
- Peter Leys, Executive Chairman, Materialise N.V.
- Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa), Stratasys
- Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology Department, Laser Zentrum Hannover

・調査結論

visiongain is a trading partner with the US Federal Government
【レポート詳細目次、データ項目一覧(List of Tables)は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

3D Printing for Healthcare: R&D, Industry and Market 2015-2025

Table of Contents

1. Report Overview

1.1 Overview of 3D Printing for Healthcare: Industry and Market 2015-2025
1.2 3D Printing for Healthcare, Market Segmentation
1.3 Market Definition
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Report
1.6 Why You Should Read This Report
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Introduction to 3D Printing for the Healthcare Industry

2.1 3D Printing
2.1.1 The Original 3D Printing Process
2.1.2 Selective Laser Sintering (SLS)
2.1.3 Direct Metal Laser Sintering (DMLS)
2.1.4 Electron Beam Melting (EBM)
2.1.5 Stereolithography (SLA)
2.2 Bio-printing: The Printing of Living Cells
2.2.1 How 3D Printing With Living Tissue Works
2.2.2 The Near- and Long-Term Applications for 3D Bio-printing
2.2.3 Current Problems With 3D Bio-printing
2.3 The 3D Printing of Pharmaceuticals
2.3.1 3D Printing Technology in Drug Discovery
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Devices Classification System

3. The 3D Printing Market for the Healthcare Industry, 2015-2025

3.1 The 3D Printing Market for Healthcare in 2013: Technology vs. Products
3.2 3D Printed Products in the Healthcare Industry: A Breakdown by Application
3.3 The 3D Printing Market for Healthcare: A Global Revenue Forecast 2015-2025
3.4 Driving and Restraining Forces Affecting That Industry
3.5 The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast 2015-2025
3.5.1 Technology: Revenue Forecast 2015-2025
3.5.2 Drivers and Restraints in the 3D Printing Technology Submarket
3.5.3 Products: Revenue Forecast 2015-2025
3.6 The 3D Printing Market for Healthcare: Application Submarket Revenue Forecasts 2015-2025
3.6.1 Dental Products: Revenue Forecast 2015-2025
3.6.2 Medical Implants: Revenue Forecast 2015-2025
3.6.2.1 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
3.6.2.2 The Driving and Restraining Factors Surrounding 3D Printed Medical Implants, 2015
3.6.3 Bio-printed Tissue: Revenue Forecast 2015-2025
3.6.4 Bio-printed Tissue: Commercial Launch in Q4 2014
3.6.5 Other Applications: Revenue Forecast 2015-2025
3.6.6 Other Applications: Medical Modelling, Prototypes and Pharmaceuticals

4. Leading National Markets for 3D Printing in Healthcare, 2015-2025

4.1 Leading National Markets – 3D Printing for Healthcare, 2013
4.2 Leading National Markets: Comparison of Revenue and Market Share, 2019 and 2025
4.3 Leading National Markets: 3D Printing for Healthcare, Grouped Revenue Forecasts, 2015-2025
4.4 The US Will Remain the Largest National Market Throughout the Forecast Period
4.4.1 Pioneering Use of 3D Printed Medical Implants in the US
4.4.2 FDA Regulatory Requirements: Abridged Pathways Encourage Innovation
4.5 The EU5 Account for 30.55% of the Market in 2013, But How Will This Change During the Forecast Period?
4.5.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.5.2 France: Strong Growth but a Decreasing Market Share
4.5.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
4.5.4 Italian Orthopaedic Device Manufacturers are Prominent Consumers of Arcam’s AM Technology
4.5.5 Spain: the Smallest Consumer in the EU5
4.6 Japan: Growth Will be Driven by Domestic and International Innovation
4.7 China: Domestic Innovation is Keeping Pace With the Western World
4.8 Will 3D Printing Penetrate the Russian Healthcare Market?
4.9 Brazil: A Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is at an Early Stage
4.11 The RoW Market is Fast Growing

5. Market Leading Organisations in 3D Printing for Healthcare

5.1 Industry leaders in 2014
5.2 Organisations in the Medical Implants Sector
5.2.1 Stratasys: Total Revenues Up Over 80% from 2013
5.2.2 3D Systems: 574% Growth in Healthcare Revenues since 2010
5.2.3 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
5.2.4 Oxford Performance Materials: Selling Two FDA Approved Facial Reconstruction Implants
5.2.5 EOS: A Manufacturer of 3D Printers
5.2.6 Within Technologies: A Manufacturer of Software for 3D Printing
5.2.6.1 Within Medical: A New Initiative Combining Medical Implant Design Software and a 3D Printing Manufacturing Program
5.2.7 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
5.2.8 Tronrud Engineering: A Provider of DMLS Since November 2011
5.2.9 Alphaform AG: Focussing on its 3D Printing Business
5.2.10 3T RPD Ltd: A UK-Based AM Company
5.2.11 Arcam AB Achieving Rapid Growth Since 2012
5.2.12 Xilloc Medical: Patient-Specific Implants from Design to Production
5.2.13 Renishaw: UK-based 3D Printer Manufacturer
5.2.14 Fripp Design and Research: Developed Picsima Technology for Printing Soft Tissue Prostheses
5.2.15 Materialise: A Global Software and Printing Services Provider
5.2.16 4WEB Medical: Over 3000 Spinal Implants Currently In Use
5.2.17 Replica 3dm: Offering Medical Models for the NHS
5.3 Organisations in the 3D Bio-printing Sector
5.3.1 Organovo: Offering the First 3D Bio-printed Tissue for Sale
5.3.2 RegenHU: Creating 3D Bio-printers and BioInks
5.3.3 Bio 3D Technologies: The World’s First Modular Bio-printer
5.3.4 Osteopore International: Two FDA Approved Products
5.3.5 EnvisionTEC: 3D Printing and Bio-printing Solutions
5.3.6 Rainbow Biosciences: Bio-printing Based on Magnetic Nanoparticles
5.3.7 Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research
5.3.7.1 Timeline for Commercially Available Therapeutic Applications
5.3.7.2 Commercial Applications: Drug Development
5.4 Organisations in Other Industry Sectors
5.4.1 Aprecia Pharmaceuticals: Oral Drug Delivery System Produced by 3D Printing Technology
5.4.2 The Cronin Group, University of Glasgow: Working on the 3D Printing of Pharmaceuticals

6. 3D Printing for the Healthcare Industry: The R&D Pipeline, 2014

6.1 R&D in the Field of Medical Implants
6.1.1 Improving Biocompatibility of 3D Printed Medical Implants with Vitamin B2
6.1.2 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3 3D Printing of Bionic Organs With Enhanced Functionality
6.1.4 Returning Vision: Printing a Bionic Eye
6.2 R&D in the Field of Bioengineering
6.2.1 3D Printing of Skin Grafts: In Hospitals Within 10 Years?
6.2.2 The Production of Implantable Cartilage Using 3D Printing
6.2.3 3D Printing Blood Vessels is a Step Towards the Fabrication of Organs
6.2.3.1 Work at the University of Pennsylvania and MIT
6.2.3.2 Work at Fraunhofer
6.2.3.3 Work at Harvard
6.2.3.4 Work at The University of Iowa
6.2.4 3D Printing of Replacement Ears for Reconstructive Surgery
6.2.5 3D Printing to Fabricate Artificial Heart Valves
6.2.6 3D Printing of Nipple Areola Complex Graft for Reconstructive Surgery
6.2.7 3D Printing of Human Embryonic Stem Cells
6.3 R&D in Other Fields
6.3.1 The 3D Printing of Pharmaceuticals: The Potential to Improve Access to Pharmaceuticals in Remote Corners of the World?
6.3.2 3D Printing Pills: University of Central Lancashire
6.3.3 Bio-robots for Targeted Drug Delivery

7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2015 Onwards

7.1 3D Printing Industry for Healthcare 2014: Strengths and Weaknesses
7.1.1 Annual Growth Rate at Highest Levels To Date
7.1.2 Demand for Customised Products is High
7.1.3 3D Printed Products Can Improve Health Outcomes and Reduce Costs
7.1.4 Time and Resources Can be Saved
7.1.5 3D Printing Can Produce Complex Shapes and Parts
7.1.6 3D Printing Technology is Advancing Rapidly
7.1.7 3D Printing is Expensive
7.1.8 Economies of Scale are not Achieved Using Current Technology
7.1.9 A More Sophisticated Technology Requires Fewer Workers and New Skills
7.1.10 Access to Technology and Expertise Currently Limited
7.2 Opportunities and Threats Facing the Industry, 2015-2025
7.2.1 Governments are Funding 3D Printing R&D Projects
7.2.2 Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity
7.2.3 There is Considerable Media Interest in the Technology
7.2.4 New Applications for 3D Printing Technology are Being Developed
7.2.5 Opportunities Exist in Post-Production Finishing
7.2.6 Regulatory Guidelines Must be Clarified
7.2.7 Long-term Studies of 3D Printed Medical Products Do Not Exist
7.2.8 Legal Questions Have Yet to be Answered
7.2.9 High Volume Manufacturing is More Economical Using Traditional Methods
7.3 A STEP Analysis of the 3D Printing Industry for Healthcare, 2015-2025
7.3.1 Social Influences on Market Trends
7.3.2 Technological Influences on Market Trends
7.3.3 Economic Influences on the Market
7.3.4 Political Influences on the Market

8. Research Interviews

8.1 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.1.1 On the Applications for 3D Bio-printing
8.1.2 On the Commercial Prospects of the Technology
8.1.3 On Potential Factors That Could Inhibit Development
8.1.4 On Their Newly Released exVive3D Liver Human Tissue
8.1.5 On the Future of Organovo and the 3D Bio-printing Industry
8.2 Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
8.2.1 On the Background of TRS
8.2.2 On TRS’ Product Portfolio
8.2.3 On Their Commercialisation Strategy
8.2.4 On TRS’ Future
8.3 Interview with Matthew Sherry, Managing Director, Replica 3dm
8.3.1 On the History Behind Replica 3dm
8.3.2 On Their Services and R&D Pipeline
8.3.3 On Replica 3dm’s Growth Plans
8.3.4 On the 3D Printing For Healthcare Industry
8.4 Interview with Professor Lee Cronin, Regius Chair of Chemistry, University of Glasgow
8.4.1 On the Cronin Group’s 3D Printed Technology
8.4.2 On Commercialisation Opportunities for Their Technology
8.5 Interview with Peter Leys, Executive Chairman, Materialise N.V.
8.5.1 On the Beginning of Materialise N.V.
8.5.2 On the Medical Products and Services Offered by Materialise N.V.
8.5.3 On Materialise’s Most Lucrative Products and Markets in 2015 and Beyond
8.5.4 On Regulatory Challenges Facing 3D Printing in the Healthcare Industry
8.5.5 On the Prospects of Materialise N.V. Over the Forecast Period
8.6 Interview with Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa), Stratasys
8.6.1 On Stratasys’ Offerings for the Healthcare Industry
8.6.2 On the Demand for 3D Printing in Healthcare
8.6.3 On the Future of 3D Printing in the Healthcare Industry
8.7 Interview with Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology Department, Laser Zentrum Hannover
8.7.1 On Laser-Assisted Bio-printing
8.7.2 On the Uses of 3D Printed Tissue
8.7.3 On 3D Printed Tissue vs. Traditional In Vitro Models
8.7.4 On 3D Printed Tissue for Transplantation
8.7.5 On Research in the Field
8.7.6 On the Timeline for Commercial Availability

9. Conclusions from Our Study

9.1 The 3D Printing Market for the Healthcare Industry: Technology vs. End Products, 2015-2025
9.2 3D Printed Products for the Healthcare Industry by Application: Comparison of Revenue, 2013, 2019 and 2025
9.3 The Leading National Markets for 3D Printing in the Healthcare Industry, 2015-2025
9.4 Trends in the Industry and Market
9.4.1 Governments Want To Be Leaders in the Field
9.4.2 Personalised Medical Products Are Penetrating The Market
9.4.3 3D Printing Technology is Already Established in the Field of Dentistry
9.4.4 Bio-printing Will Take-Off Over The Next 10 years
9.4.5 Submarkets Will Expand – Systems, Software, Raw Materials & Products

List of Tables

Table 1.1 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2014-2025
Table 2.1 The US Classification of Medical Devices
Table 2.2 The EU Classification of Medical Devices
Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2013
Table 3.2 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%), 2013
Table 3.3 3D Printing in the Healthcare Industry: Overall World Revenue ($m) Forecast, 2014-2025
Table 3.4 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2014-2025
Table 3.5 3D Printed Products for Healthcare: Revenue Forecast ($m), 2014-2025
Table 3.6 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2014-2025
Table 3.7 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 3.8 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 3.9 Bio-printed Tissue: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 3.10 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.1 Leading National Markets for 3D Printing Technology and 3D Printed Products for Healthcare: Revenue ($m) and Market Share (%), 2013
Table 4.2 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2019 and 2025
Table 4.3 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Revenue Forecasts ($m), 2014-2025
Table 4.4 The US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.5 The EU5: National Revenue ($m) and Market Share (%) Forecasts, 2014-2025
Table 4.6 The German 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.7 The French 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.8 The UK 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.9 The Italian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.10 The Spanish 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.11 The Japanese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.12 The Chinese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.13 The Russian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.14 The Brazilian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.15 The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 4.16 RoW Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025
Table 5.1 Prominent Organisations in the 3D Printing Market for the Healthcare Industry, End of 2014
Table 5.2 Prominent Organisations in the Medical Implant Market, End of 2014
Table 5.3 Stratasys’ Acquisition History, 2013-2014
Table 5.4 3D Systems Healthcare Revenue ($m) and Share (%) of Total Revenue, 2010-2014
Table 5.5 3D Systems Healthcare-Related Acquisition History, 2012-2014
Table 5.6 Medical Implants Designed by Within Technologies' Software, 2014
Table 5.7 Alphaform AG’s Revenue ($m), 2010-2014
Table 5.8 Arcam Revenues ($m), 2010-2014
Table 5.9 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2013
Table 5.10 Materials Used by Xilloc Medical, 2014
Table 5.11 Prominent Organisations in the 3D Bio-printing Market, 2014
Table 5.12 EnvisionTEC 3D Printing Systems for the Medical and Dental Industries, 2014
Table 5.13 Prominent Organisations in Other Industry Sectors Using 3D Printing, 2014
Table 6.1 Improving Biocompatibility of 3D Printed Medical Implants: Main Facts, 2014
Table 6.2 3D Printing Intervertebral Discs: Main Facts, 2014
Table 6.3 3D Printing of Bionic Organs: Main Facts, 2014
Table 6.4 3D Printing of Bionic Eye: Main Facts, 2014
Table 6.5 3D Printing of Skin Grafts: Main Facts, 2014
Table 6.6 3D Printed Cartilage: Main Facts, 2014
Table 6.7 3D Printing of Blood Vessels: Main Facts, 2014
Table 6.8 3D Printing of Replacement Human Ears: Main Facts, 2014
Table 6.9 3D Printing of Heart Valves: Main Facts, 2014
Table 6.10 3D Printing of Pharmaceuticals: Main Facts, 2014
Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2014-2015
Table 7.2 Opportunities and Threats Facing the Industry and Market, 2015-2025
Table 7.3 Governmental Funding for 3D Printing, 2011-2014
Table 7.4 STEP Analysis: Social, Technological, Economic and Political Forces Influencing the 3D Printing Market for Healthcare, 2015-2025
Table 7.5 Main Technological Advances in 3D Printing to End of 2014

List of Figures

Figure 1.1 Global 3D Printing for Healthcare Market Segmentation Overview
Figure 3.1 Breakdown of the Market by Technology and Products: Market Share (%), 2013
Figure 3.2 3D Printed Products for Healthcare by Application: Market Share (%), 2013
Figure 3.3 3D Printing in the Healthcare Industry: An Overarching Revenue Forecast ($m), 2015-2025
Figure 3.4 3D Printing in the Healthcare Industry: Annual Growth Rates, 2015-2025
Figure 3.5 Driving and Restraining Factors of 3D Printing for Healthcare, 2015
Figure 3.6 3D Printing Technology for Healthcare: Market Share (%), 2019
Figure 3.7 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 3.8 Driving and Restraining Factors of 3D Printing Technology in the Healthcare Industry, 2015
Figure 3.9 3D Printed Products for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 3.10 3D Printed Products and Technology for Healthcare: Market Share (%), 2025
Figure 3.11 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 2014-2025
Figure 3.12 3D Printed Products by Application: Market Share (%), 2025
Figure 3.13 3D Printed Dental Products: Revenue Forecast ($m), 2014-2025
Figure 3.14 Driving and Restraining Factors of the 3D Printed Dental Product Market, 2015
Figure 3.15 3D Printed Medical Implants: Revenue Forecast ($m), 2014-2025
Figure 3.16 Driving and Restraining Factors of the 3D Printed Medical Implants Market, 2015
Figure 3.17 Bio-printed Tissue: Revenue Forecast ($m), 2014-2025
Figure 3.18 Driving and Restraining Factors of the 3D Bio-printing Market, 2015
Figure 3.19 Other Applications: Revenue Forecast ($m), 2014-2025
Figure 3.20 The Driving and Restraining Factors of the Market for Other Applications, 2015
Figure 4.1 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2013
Figure 4.2 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share Forecast (%), 2013, 2019, 2025
Figure 4.3 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Grouped Revenue Forecast ($m), 2014-2025
Figure 4.4 The US 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.5 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2013
Figure 4.6 The EU5: National Revenue Forecasts ($m), 2014-2025
Figure 4.7 The German 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.8 The French 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.9 The UK 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.10 The Italian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.11 The Spanish 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.12 The Japanese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.13 The Chinese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.14 The Russian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.15 The Brazilian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.16 The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 4.17 RoW 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025
Figure 5.1 3D Systems Healthcare Revenue ($m), 2010-2014
Figure 5.2 Alphaform AG’s Revenue ($m), 2010-2014
Figure 5.3 Arcam: Breakdown of System Sales by Industry, 2005-2014
Figure 5.4 Arcam: Breakdown of System Sales by Location, 2005-2014
Figure 5.5 Arcam Revenues ($m), 2010-2014
Figure 5.6 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2013
Figure 5.7 Materialise: Revenue Breakdown by Application, 2014 (Q1-Q3)
Figure 6.1 3D Printing Technology for Healthcare: Outline of the R&D Pipeline, 2014
Figure 8.1 Orthodontic Model Produced on a Stratasys Objet30 OrthoDesk 3D Printer
Figure 8.2 VeinViewer® Flex Designed Using Stratasys 3D Printed Prototypes
Figure 8.3 VeinViewer® Displaying Blood Beneath the Surface of an Adult Female Hand
Figure 8.4 Jorge Vicente Lopes da Silva, Chief of Tridimensional Technologies Division (DT3D - CTI), Shows 12-year-old Boy’s Skull Model Produced on an Objet350 Connex Multi-material 3D Printer. That child Suffered an Accident and Lost Part of his Cranium.
Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Down Into Technology and Products, 2014-2025
Figure 9.2 3D Printed Products for the Healthcare Industry by Application: Comparisons of Revenue ($m), 2013, 2019 and 2025
Figure 9.3 Leading National Markets in the 3D Printing Industry for Healthcare: Comparisons of Revenue ($m), 2013, 2019 and 2025

掲載企業リスト

Companies Listed

3D Systems
3T RPD
4WEB Medical
5N Plus
Adler Ortho
Alphaform AG
AP&C
Aprecia Pharmaceuticals
Arcam AB
Asian Manufacturing Association
Autodesk
BestinClass SA
Bio 3D Technologies
Biomet
Bionics Institute
C&A Tool
Canon
Chinese Food and Drug Administration
Clemson University
Compass3D
Cornell University
CPA Group
CTI Renato Archer
Dante Pazzanese Cardiology Institute
DePuy Synthes
Deutsches Herzzentrum Berlin
DiSanto Technology
EnvisionTEC
EOS
Epson
ETH Zurich
European Commission
European Medicines Agency
FirstSurface Ltd
Food and Drug Administration
Formlabs
Fraunhofer Institutes
Fripp Design and Research
Geomagic
GrabCAD
Hangzhou Dianzi University
Harvard University
Harvest Technologies
Herriot-Watt University
Hewlett-Packard
Imaginarium
Industry Alliance of China 3D Printing Technology
Interfacial Solutions
inVentiv Health
Invetech
Janssen Research and Development
Johns Hopkins University
Johnson & Johnson
Kyoto University Graduate School of Medicine
Laser Zentrum Hannover
LayerWise
Lima Corporate
Maastricht Instruments B.V.
MakerBot
Manchester Metropolitan University
Massachusetts Institute of Technology
Materialise NV
Mattel Children's Hospital
MCP HEK Tooling
Medical Modeling Inc.
Medicines and Healthcare Regulatory Agency
Medtronic
Ministry of Industry and Information technology
Mobelife
Nakashima Medical
Nano 3D Biosciences
National Additive Manufacturing Innovation Institute
National Institute of Health
National Network for Manufacturing Innovation
North Carolina State University
OBL
Organovo
Osteopore International
Oxford Performance Materials
Paramount Industries
Peking University 3rd Hospital
Pfizer
Princeton University
Protosys Technologies
Queen's Medical Centre
QuinXell Technologies
Rainbow BioSciences
Rainbow Coral Corp.
RedEye
RegenHU
Renishaw
Replica 3dm
Riton Biomaterial Co. Ltd
Roche
Roslin Cellab
Royal Perth Hospital
Salisbury District Hospital
Simbionix
Sixense
SkinPrint
Smith & Nephew
Solid Concepts
Sony DADC
Stratasys
Stryker
Technology Strategy Board
TeVido Biodevices
The Cronin Group
The Knight Cancer Institute of Oregon Health and Science University
The Michael J Fox Foundation
Tissue Regeneration Systems
Tronrud
TU Berlin
UCLA
United Therapeutics
University of Central Lancashire
University of Glasgow
University of Iowa
University of Michigan
University of North Carolina
University of Nottingham
University of Pennsylvania
University of Pittsburgh
University of Sheffield
University of Wisconsin
US Army
Vidar Systems Corp.
VIVOS Dental
Wake Forest Institute for Regenerative Medicine (WFIRM)
Walter Reed National Military Medical Centre
Weill Cornell Medical College
Wellcome Trust
Within Technologies
World Health Organisation (WHO)
Wyss Institute at Harvard University
Xilloc Medical
Zimmer

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

関連レポート紹介

LinkIcon医療用ロボットの世界市場2015-2025年

現在、分野的には手術ロボットが技術進化と研究開発パイプラインの豊富さという点で、最もダイナミックな市場となっています。高齢化する人口、政府の財政補助、FDAの取り組み、技術的進化、そして病院・薬局ロボット分野の急成長などは、今後10年間の市場促進要因といえるでしょう。

LinkIcon世界の3Dプリンターテクノロジー市場2014-2019年

3Dプリンター市場はこの先20年間で爆発的な成長が見込まれ、2014年から2019年までの5年間はこの分野にとって実り多い導入期と初期イノベーションの時期と位置づけることができるでしょう。新世代の製造プロセスのための基礎は敷かれつつあり、リーディング企業にとっては開拓すべきニッチ市場も多く存在しています。

2319881.jpg国内外のスマートグリッド関連ニュース、リサーチ情報等を収集し隔週でお届けいたします。日本そして海外の企業動向、新製品、政府支援、技術開発、規格、導入事例、投資、調査発表など幅広く情報を定期配信いたします。
スマートグリッド・ニュースへLinkIcon


ニュースページへLinkIcon

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。